Clinical trial
Bioequivalence Study of Dronedarone Hydrochloride Tablets
NCT07396519 is registered in ClinicalTrials.gov with Shandong New Time Pharmaceutical Co., LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioequivalence Study of Dronedarone Hydrochloride Tablets
- Lead sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 14, 2022
- Completion date
- December 7, 2022
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation (af)